A groundbreaking study reveals the potential of alternative donors in bone marrow transplantation, paving the way for improved patient outcomes and innovative practices.
Stephanie Lee, MD
Stephanie Lee, MD, is a hematologist/oncologist at the Fred Hutchinson Cancer Center in Seattle, WA. She is also a professor and associate director of the clinical research division and David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research at Fred Hutch.
Articles by Stephanie Lee, MD
Innovative research transforms bone marrow transplantation, enhancing outcomes with mismatched and haploidentical donors, expanding access to life-saving treatments.
A new study reveals that optimized donor search algorithms significantly enhance transplant outcomes for patients, even with alternative donor sources.
A new study explores strategies to enhance survival rates for patients facing challenges in finding bone marrow donors, advocating for quicker alternative options.
Stephanie Lee, MD, discusses a study investigating belumosudil for chronic graft-vs-host disease.
Stephanie Lee, MD, MPH, discusses the effectiveness of ruxolitinib within various settings for patients with chronic graft-versus-host disease.
Latest Updated Articles
Equivalent Outcomes: Alternative Donors Match Matched Unrelated TransplantsPublished: October 10th 2025 | Updated:
Belumosudil Shows Sustained Efficacy and Safety for Chronic GVHDPublished: March 11th 2024 | Updated:
Possibilities for Ruxolitinib in Various cGVHD Patient PopulationsPublished: February 12th 2022 | Updated:
- Upfront Donor Assessment Improves Transplant Survival for High-Risk Patients
Published: October 9th 2025 | Updated: